Drug factory · FDA FEI 3004072297
Zhejiang Xianju Junye Pharmaceutical Co., Ltd.(Yangfu site)
No. 1 Lingxiu Road, Modern Industrial Centralization Zone Xianju, Taizhou, China
No problems found at FDA's last inspection, Jul 11, 2025.
No Action Indicated: inspectors found no objectionable conditions.
3 drug inspections on record since 2015: 2 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Abiraterone and Niraparib | Makes the active ingredient | Janssen Biotech, Inc. | 57894-050, 57894-100 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jul 11, 2025 | No problems found | Drug Quality Assurance | — |
| Jan 11, 2019 | No problems found | Drug Quality Assurance | — |
| Feb 13, 2015 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: api manufacture.